2022 - Research.com Best Scientist Award
2006 - Distinguished Fellowship Award, American College of Cardiology (ACC)
1999 - Fellow of the American Association for the Advancement of Science (AAAS)
1982 - Fellow of American Physical Society (APS)
Member of the Association of American Physicians
His primary areas of investigation include Internal medicine, Immunology, Inflammation, Endocrinology and Atheroma. The study incorporates disciplines such as Placebo, Surgery and Cardiology in addition to Internal medicine. His research in Immunology intersects with topics in Endothelium and Macrophage.
His Inflammation study incorporates themes from Disease, Pathology, Immune system and CD40. Peter Libby has included themes like Vascular disease and Intensive care medicine in his Disease study. His study in Endocrinology is interdisciplinary in nature, drawing from both Peroxisome proliferator-activated receptor, HMG-CoA reductase, Cytokine and Cell biology.
Internal medicine, Inflammation, Immunology, Pathology and Endocrinology are his primary areas of study. Peter Libby interconnects Placebo and Cardiology in the investigation of issues within Internal medicine. His Cardiology research incorporates elements of Thrombosis and Rosuvastatin.
His Inflammation research includes elements of Tumor necrosis factor alpha, Disease, Vascular disease and Cell biology. Peter Libby has researched Immunology in several fields, including Macrophage and Transplantation. In his research on the topic of Pathology, Extracellular matrix is strongly related with Matrix metalloproteinase.
His scientific interests lie mostly in Internal medicine, Inflammation, Immunology, Myocardial infarction and Disease. His biological study spans a wide range of topics, including Placebo, Endocrinology and Cardiology. His study on Inflammation also encompasses disciplines like
His Immunology and Immune system and Monocyte investigations all form part of his Immunology research activities. His work on Myocardial infarction is being expanded to include thematically relevant topics such as Stroke. The study incorporates disciplines such as Risk factor and Intensive care medicine in addition to Disease.
Peter Libby mostly deals with Internal medicine, Inflammation, Disease, Immunology and Myocardial infarction. Internal medicine is closely attributed to Cardiology in his research. His Inflammation research includes themes of Innate immune system, Bone marrow, Pathology and Immunity.
His Pathology research is multidisciplinary, incorporating perspectives in Endothelium, Plaque rupture, Plaque erosion and In vivo. The concepts of his Disease study are interwoven with issues in Ageing, Stem cell, Bioinformatics and Intensive care medicine. His Myocardial infarction research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inflammation and Atherosclerosis
Peter Libby;Paul M. Ridker;Attilio Maseri.
Inflammation in atherosclerosis
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto.
The New England Journal of Medicine (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest.
Obstetrical & Gynecological Survey (2009)
From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I
Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen.
The New England Journal of Medicine (2017)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby;Paul M Ridker;Göran K. Hansson.
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Joshua A. Beckman;Mark A. Creager;Peter Libby.
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
Z S Galis;Galina K. Sukhova;M W Lark;Peter Libby.
Journal of Clinical Investigation (1994)
Molecular bases of the acute coronary syndromes
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: